2 million SA vaccines had to be destroyed - but US bosses get bonuses despite problems at factory

accreditation
0:00
play article
Subscribers can listen to this article
Emergent BioSolutions disposed of 15 million doses of J&J vaccine in March. Photo by Tasos Katopodis / Getty Images
Emergent BioSolutions disposed of 15 million doses of J&J vaccine in March. Photo by Tasos Katopodis / Getty Images
Photo by Tasos Katopodis / Getty Images
  • The US biotech firm Emergent enjoyed its best financial year in 20 years, and five executives received R115 million in bonuses, The New York Times reported.
  • This is despite massive problems at the company's plant, which meant that 75 million J&J vaccines can't be used.
  • Two million vaccines for South Africans also had to be destroyed as a result.


The New York Times reported this week that five executives of biotech firm Emergent received nearly R115 million ($8 million) in cash and stock awards in recent weeks – despite the fact that 75 million Johnson & Johnson vaccines can't be used due to problems at the company’s Baltimore plant.

Two million desperately-needed vaccines meant for South Africans – manufactured at Aspen’s Gqeberha plant using ingredients from the Emergent plant - also had to be destroyed as a result.

Since April, the distribution of locally made J&J vaccines was put on hold due to the problems in Baltimore – a crippling blow to South Africa’s vaccine campaign in the run-up to a third Covid-19 wave, which has now gripped the country.

"You just wonder how many lives you may have been able to save if you could [have] distributed the product at the end of April," Aspen CEO Stephen Saad said in interview with The Money Show with Bruce Whitfield on Tuesday. He added that he was "disappointed that [the problems at the US factory] happened at all", and expressed concern about the knock-on effect on South Africa, as the Covid-19 caseload surges in the country.

Workers at Emergent BioSolutions in Baltimore accidentally mixed up some of the ingredients, and an investigation by US authorities also revealed that the factory did not seal off a preparation area for vaccine ingredients, with waste materials moving through the area.

The New York Times previously reported that audits and investigations into the Baltimore factory flagged a persistent problem "with mould in areas required to be kept clean, poor disinfection of some plant equipment leading to growth of bacteria, the repeated approval of raw materials that had not been fully tested, and inadequate training of some employees".

Last year, Emergent received a $628 million contract from the Trump administration - with no competitive bidding – to bottle and package vaccines, The New York Times reported this week.

This helped the "the politically connected company" to enjoy its best financial year in two decades, even though its Baltimore factory "had failed to deliver a single usable vaccine dose" until last week. In addition, the production lines at its two other sites have mostly sat idle, the newspaper reported.

Meanwhile, Aspen has switched to using vaccine ingredients from Europe a month ago, and Saad says that by Monday next week, "a fresh batch" of vaccines will be released from its South African facility, which can produce 300 million doses a year.

Saad says that Aspen has "plenty of material" that will help it to produce millions of doses in the next few months.

We live in a world where facts and fiction get blurred
In times of uncertainty you need journalism you can trust. For only R75 per month, you have access to a world of in-depth analyses, investigative journalism, top opinions and a range of features. Journalism strengthens democracy. Invest in the future today.
Subscribe to News24
Rand - Dollar
14.79
+0.4%
Rand - Pound
20.35
+0.3%
Rand - Euro
17.41
+0.4%
Rand - Aus dollar
10.89
+0.4%
Rand - Yen
0.13
+0.3%
Gold
1,802.28
0.0%
Silver
25.18
0.0%
Palladium
2,675.50
0.0%
Platinum
1,064.50
0.0%
Brent Crude
74.10
+0.4%
Top 40
61,933
+1.0%
All Share
68,064
+1.0%
Resource 10
66,904
+1.5%
Industrial 25
89,442
+0.7%
Financial 15
12,820
+1.0%
All JSE data delayed by at least 15 minutes Iress logo
Company Snapshot
Voting Booth
In light of the recent looting, do you think a basic income grant is the right approach to deal with SA’s hunger and poverty problems?
Please select an option Oops! Something went wrong, please try again later.
Results
It will go a long way in helping fight the symptoms of SA’s entrenched inequality, especially for those who are starving right now
20% - 1287 votes
SA’s problems are complex, and we instead need to spend that money on building and growing our economy, which will help the country in the long run
31% - 2038 votes
All grants are a problem as they foster a reliance on handouts
49% - 3232 votes
Vote